Anti-CD22 / BL-CAM, clone CBO-3

Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5mg/ml BSA. CD22 (BL-CAM) is a B cell-specific transmembrane glycoprotein that functions as an inhibitory receptor, regulating B cell receptor (BCR) signaling. It belongs to the immunoglobulin superfamily and modulates B cell activation thresholds, helping maintain immune tolerance and prevent overactivation of the immune response. CD22 is primarily expressed on mature B cells and plays a role in B cell survival, adhesion, and migration within lymphoid tissues. Altered CD22 expression or function has been associated with autoimmune diseases and B cell malignancies, making it an important biomarker and therapeutic target in immunology and oncology research. Using a high-quality CD22 antibody enables sensitive detection in applications such as flow cytometry, immunohistochemistry, and western blot. A CD22 antibody from NSJ Bioreagents ensures reproducibility and accuracy for studies in B cell biology, immune regulation, and cancer research. Selecting the right CD22 antibody is critical for generating consistent and reliable experimental results.